The PROMISE program at LMU Munich supports advanced clinician scientists combining clinical practice with independent neuroscience research. Four selected fellows are featured: Dr. Sarah Häbe, whose ECLIPSE project investigates central nervous system lymphoma and its immune-privileged tumor environment; PD Dr. Anna Kopczak, who develops mechanism-based carotid plaque imaging to improve stroke risk stratification; Dr. Carla Palleis, who investigates precision biomarkers for the early diagnosis, monitoring, and staging of progressive supranuclear palsy; and PD Dr. Franziska Thaler, who studies autoreactive B cells in autoimmune encephalitis. Their projects aim to advance disease understanding, improve diagnostics, and support more precise, effective patient care.

The second selection round will be 2027.